Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Propofol Anesthesia for ECT in Treatment-Resistant Depression
NCT01935115Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Sep 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by University of Saskatchewan. Started Sep 2013; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01935115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935115.